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Taru Ilmarinen1, Karin Blomgren1
1 Department of Otorhinolaryngology—Head and Neck Surgery, Helsinki University Hospital, Helsinki,
Finland, 2 Department of Virology, University of Helsinki, Helsinki, Finland, 3 Department of Oral and
Maxillofacial Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
* enni@sanmark.fi
Abstract
The present study aimed to specify diagnostics for peritonsillar abscesses (PTAs) and to
clarify the role of minor salivary glands. This prospective cohort study included 112 patients
with acute tonsillitis (AT) and PTA recruited at a tertiary hospital emergency department
between February and October 2017. All patients completed a questionnaire concerning
their current disease. Serum amylase (S-Amyl) and C-reactive protein (S-CRP) levels, ton-
sillar findings, and pus aspirate samples and throat cultures were analyzed. Eight of 58 PTA
patients (13.8%) had no signs of tonsillar infection. The absence of tonsillar erythema and
exudate was associated with low S-CRP (p<0.001) and older age (p<0.001). We also
observed an inverse correlation between S-Amyl and S-CRP levels (AT, r = -0.519; PTA, r =
-0.353). Therefore, we observed a group of PTA patients without signs of tonsillar infection
who had significantly lower S-CRP levels than other PTA patients. These findings support
that PTA may be caused by an etiology other than AT. Variations in the S-Amyl levels and a
negative correlation between S-Amyl and S-CRP levels may indicate that minor salivary
glands are involved in PTA development.
Introduction
Acute tonsillitis (AT) is a highly prevalent infection that is responsible for a large number of
consultations. Peritonsillar abscess (PTA) is the most common deep head and neck infection,
with an incidence of 10–41/100,000 [1–5], and traditionally regarded as a purulent complica-
tion of AT, but the evidence for an association between the two is uncertain. PTA may appear
after tonsillectomy (TE) without tonsillar remnants, as Windfuhr et al. demonstrated, and the
seasonal incidence of the two entities does not follow a symmetrical pattern [1, 6–8]. Over the
last three decades, PTA has been speculated to not necessarily arise from AT, but as a conse-
quence of poor dental health, smoking, and salivary dysfunction. Minor salivary glands have
been suggested to play a significant role in PTA [3, 8, 9].
PLOS ONE







Citation: Sanmark E, Wikstén J, Välimaa H,
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Shared symptoms of AT and PTA are sore throat and fever. PTA patients also suffer from
trismus, and the pain is typically asymmetrical [10, 11]. In both AT and PTA, common clinical
findings include tonsillar exudate and enlarged cervical lymph nodes. PTA patients also often
have asymmetric peritonsillar swelling [11, 12]. The diagnosis of AT and PTA is clinical, but a
recent review recommended measuring C-reactive protein (CRP) and performing a full blood
count in all PTA patients, though the benefits of laboratory tests in the diagnosis or treatment
of PTA are unclear. As dehydration is a common symptom of PTA, electrolytes should also be
analyzed [2]. Tachibana et al. reported higher serum leukocyte levels in PTA patients than AT
patients, but did not observe differences in CRP levels. In addition, higher serum CRP
(S-CRP) levels predicted slower healing after PTA; the mean S-CRP in PTA patients was 85
mg/l (1.3–380 mg/l) [13, 14].
Salivary amylase levels can serve as a marker of salivary function, and recent studies have
shown that both serum and pus amylase levels are highly elevated in PTA patients compared
to patients with other neck abscesses and dental abscesses. In PTA patients, the mean serum
amylase level is 50 U/l and mean pus amylase level 3045 U/l (range 20–11,000 U/l) [15–17].
Group A streptococci (GAS) are the most prevalent bacteria causing both AT and PTA [9–
11, 18]. Several studies have reported other bacteria (e.g., other beta-hemolytic streptococci
[groups C and G] and Fusobacterium necrophorum [FN]) as major pathogens in AT [19, 20],
and FN has been recognized as a major pathogen in PTA. In addition, Streptococcus anginosus
group (SAG) streptococci have been reported as important pathogens in peritonsillar infec-
tions and observed to predict the recurrence of PTA [21, 22]. PTAs caused by FN are associ-
ated with significantly increased CRP and neutrophil levels compared to PTAs caused by other
pathogens [22].
Although the clinical picture of PTAs is diverse, previous studies concerning PTA diagnos-
tics have considered these patients as a uniform group. The aim of this study was to clarify the




The study included 112 patients referred to Helsinki University Hospital Department of
Otorhinolaryngology for AT or PTA between February and October 2017. Exclusion criteria
were age<15 years or pancreatic disease due to the changes in serum amylase levels caused by
pancreatic destruction [23]. Patients were divided into two subgroups based on clinical diag-
nosis: AT (n = 54) or PTA (n = 58). All patients completed a questionnaire concerning their
smoking habits, overall health, current disease, prior antibiotics during the current infection,
alcohol consumption, and previous tonsillar or peritonsillar infections. The emergency depart-
ment physician completed a structured form concerning tonsillar findings, and the physicians
evaluated the dental health and oral hygiene (good/poor) by inspecting the oral cavity. Blood
samples were collected from all patients, and S-CRP and serum amylase (S-Amyl) levels were
analyzed. The PTA patients were also treated with incision and drainage (ID). Pus aspirate
samples from PTA patients and throat swabs from AT patients were taken for bacterial
culture.
Bacterial culture was performed at Helsinki University Hospital Laboratory Services (HUS-
LAB). Pus samples were grown under both aerobic and anaerobic conditions and the superfi-
cial throat swabs under aerobic conditions according to the laboratory’s standard methods for
diagnostic samples. The bacterial culture results were recorded from the hospital laboratory
database as reported by the diagnostic laboratory. For the analysis, all isolates of beta-
PLOS ONE Etiology of peritonsillar abscess
PLOS ONE | https://doi.org/10.1371/journal.pone.0228122 April 3, 2020 2 / 12
Funding: This work was supported by the Finnish
ORL-HNS Foundation to ES; Foundation of
Dorothea Olivia, Karl Walter, and Jarl Walter
Perklén’s memory (201700022) to ES; and the
Helsinki University Hospital Research Fund to KB.
Competing interests: The authors have declared
that no competing interests exist.
Abbreviations: PTA, Peritonsillar abscess; AT,
acute tonsillitis; GAS, Group A streptococcus; FN,
Fusobacterium necrophorum; SAG, Streptococcus
anginosus group; ID, incision and drainage.
hemolytic streptococci, SAG and FN, Haemophilus influenzae, Staphylococcus aureus, and
heavy growth of Neisseria meningitidis were recorded as separate isolates. Non-FN anaerobic
isolates were combined and classified as other anaerobic bacteria. In addition, the reported
mixed normal flora was recorded as mixed regional flora.
Ethical considerations
All procedures that involved human participants were conducted in accordance with the ethi-
cal standards of the institutional or national research committee and with the 1964 Declaration
of Helsinki and its later amendments or comparable ethical standards. The Ethics Committee
of Helsinki University Hospital approved the study protocol. All patients provided written
informed consent prior to their participation. According to Finnish legislation, minors over 15
years of age are entitled to give their informed consent without guardian’s permission. All pro-
vided study information was, however, adjusted for their age group.
Main outcome measures
Correlations between smoking, alcohol consumption, signs and symptoms of infection, labo-
ratory tests, oral health, and bacterial findings were analyzed and compared between the AT
and PTA patients. The main aim of these analyses was to determine whether any differences
were present in laboratory tests, oral health, or symptoms between AT and PTA patients. In
addition, we examined whether different subgroups of AT or PTA patients exist and whether
laboratory values, bacterial findings, certain symptoms, smoking, or oral health are related to a
specific subgroup of patients.
Statistical analysis
Statistical analyses were performed using NCSS 8 statistical software (Hintze, J. [2012]; NCSS
8, NCSS, LLC, Kaysville, UT, USA; www.ncss.com). The FN and FN+SAG groups were com-
bined in the statistical analysis due to the small number of patients in the groups. Numerical
variables were analyzed by the Mann-Whitney U-test and Kruskal-Wallis one-way ANOVA.
Chi-squared was applied to compare nominal variables. The Spearman rank-correlation was
applied to two numerical variables with non-normal distribution. P-values<0.05 were consid-
ered significant.
Results
A total of 112 patients were included in the study. Patient characteristics and clinical data are
presented in Table 1. None of the patients developed a complication during the first 3 months.
Serum amylase and C-reactive protein levels
A significant inverse correlation was observed between S-Amyl (normal reference 28–100 U/l)
and S-CRP (normal reference 0.05–3 mg/l) levels in both the AT and PTA groups (AT, r =
-0.519, p�0.001; PTA, r = -0.353, p�0.001; Fig 1). We found no differences in the S-Amyl or
S-CRP levels between the AT and PTA groups (S-Amyl, p = 0.767; S-CRP, p = 0.501). Alcohol
consumption and smoking habits had no effect on S-Amyl levels (alcohol, p = 0.750; smoking,
p = 0.205). No correlation was found between age and CRP (AT and PTA patients r = -0.094,
p = 0.342; PTA patients r = -0.137, p = 0.329). The S-Amyl and S-CRP levels in AT and PTA
patients are presented in Table 2.
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Table 1. Patient characteristics.
Characteristic All PTA patients (n = 58) AT patients (n = 54) PTA patients without tonsillar findings (n = 8)
Age, years
Median 36 28.5 50.5
Range 16–65 15–86 24–65
Gender
Male 36 (62.1) 21 (38.9) 5 (62.5)
Female 22 (37.9) 33 (61.1) 3 (37.5)
Smoking
Non-smoker 21 (36.8) 20 (37.0) 5 (62.5)
Smoker 24 (41.4) 22 (40.7) 2 (25.0)




No 36 (62.1) 31 (57.4) 4 (50.0)
No information 21 (36.2) 23 (42.6) 4 (50.0)
1
Prior antibiotics for more than 24 hours
Yes 10 (17.2) 9 (16.7) 1 (12.5)
No 48 (82.8) 45 (83.3) 7 (87.5)
Duration of symptoms a prior to PTA
1–3 Days
>3 days
16 (27.6) 28 (51.9) 2 (25.0)
42 (72.4) 26 (48.1) 6 (75.0)
Unilateral throat pain
Yes 54 (93.1) 31 (60.8) 8 (100.0)
No 4 (6.9) 20 (39.2) 0 (0)
No information 3
Fever
Yes 38 (65.5) 41 (75.9) 3 (37.5)
No 20 (34.5) 13 (24.1) 5 (62.5)
Symptoms of common cold
Yes
No 16 (27.6) 23 (44.2) 2 (25.0)
No information 42 (72.4) 29 (55.8) 2 6 (75.0)
Prior tonsillar infection
AT 13 (22.8) 12 (22.2) 0(0)
CT 1 (1.8) 1 (1.9) 0 (0)
PTA 8 (14.0) 2 (5.6) 2 (25.0)




Erythema 16 (28.1) 16 (30.2) 0 (0)
Both 26 (45.6) 16 (30.2) 0 (0)
None 7 (12.3) 21 (39.6) 0 (0)
No information 8 (14.0) 0 (0) 8 (100.0)
(Continued)
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Tonsillar findings
In patients with AT, the presence of tonsillar erythema, tonsillar exudate, or both had no effect
on S-Amyl (p = 0.306) or S-CRP (p = 0.363) levels. In the PTA group, eight patients did not
have tonsillar erythema or tonsillar exudate. These eight PTA patients had significantly lower
S-CRP levels (median 15 mg/l, range 3–40 mg/l) than PTA patients presenting with tonsillar
findings (median S-CRP 60 mg/l, range 3–313 mg/l; p<0.001). S-Amyl levels were slightly, but
not significantly (p = 0.190), higher in these eight patients (median 49 U/l, range 27–82 U/l)
compared to the other PTA patients (median 41 U/l, range 15–116 U/l; Fig 2). PTA patients
without tonsillar findings were significantly older (median age 50.5 years, range 24–65 years)
than the other PTA patients (median age 34 years, range 16–60 years; p = 0.006). Of the 58
PTAs, two (3.4%) were bilateral. Oral health had no impact on bacterial findings in either
group.
Table 1. (Continued)




Poor 52 (91.2) 48 (90.6) 7 (87.5)
No information 5 (8.8) 5 (9.4) 1 (12.5)
1 1
Data are presented as n (%) unless otherwise noted. PTA, peritonsillar abscess; AT, acute tonsillitis; CT, chronic tonsillitis
a Throat pain, fever, hoarseness.
https://doi.org/10.1371/journal.pone.0228122.t001
Fig 1. Correlation between serum amylase and C-reactive protein levels. (A) Patients with acute tonsillitis (r = -0.519, p�0.001).
(B) Patients with peritonsillar abscess (r = -0.353, p�0.001).
https://doi.org/10.1371/journal.pone.0228122.g001
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Bacterial findings
Bacterial samples were taken from all but two PTA patients. The bacterial findings are pre-
sented in Table 3. The most common bacteria isolated in AT patients were GAS (41.7% of all
samples), group B, C, and G beta-hemolytic streptococci (3.7%), and H. influenzae (3.7%). In
51.9% of AT patients, only normal mixed tonsillar flora was reported. In PTA patients, anaero-
bic Gram-negative rods were a common finding (n = 27, 37.5% of all samples), including FN
isolated from five patients. GAS and SAG were isolated from an almost equal number of sam-
ples (18.1% vs. 15.3%). In three samples, SAG was found together with FN. H. influenzae, N.
meningitidis, and S. aureus isolates were found together with anaerobic Gram-negative rods.
N. meningitidis growth was heavy and included as a separate finding. One bacterial sample in
the PTA group was negative.
The bacteria isolated from the eight PTA patients without tonsillar findings were GAS
(n = 2), S. aureus (n = 2), FN (n = 1), anaerobic Gram-negative rods (n = 5), and mixed aerobic
flora (n = 1). S. aureus was isolated together with anaerobic Gram-negative rods in both cases.
All of these bacteria were also isolated in other PTA patients; therefore, we found no obvious
difference between the two groups in the bacterial etiology of the disease.
No differences were found in the S-Amyl or S-CRP levels between the bacterial findings in
either the AT or PTA group (AT, S-Amyl p = 0.620, S-CRP p = 0.331; PTA, S-Amyl p = 0.925,
S-CRP p = 0.203). Bacterial findings were not associated with any of the recorded specific
Table 2. Serum amylase and CRP levels in AT (n = 52) and PTA (n = 54) patients with different infection symptoms.
Median amylase in AT (U/l) Median CRP in AT (mg/l) Median amylase in PTA (U/l) Median CRP in PTA (mg/l)
Fever
Yes 37.5 104.5 44 82
No 65.5 15 46 40
p-value 0.0212 0.00037 0.637 0.239
Symptom duration
<3 days 39 94 36 74
>3 days 42 80 44 59
p-value 0.650 0.063 0.655 0.720
Unilateral pain 46 75.5 44 60
Bilateral pain 30.5 110 32.5 120.5
p-value 0.033 0.031 0.175 0.522
Common cold
Yes 41 94 51 36
No 38.5 90 41 82
p-value 0.914 0.575 0.0096 0.0755
Oral hygiene
Normal/Good 39.5 87 41 67
Poor 42 92 48 36
p-value 0.862 0.874 0.484 0.447
History of
AT 34 90 46 105
PTA 35 36
None 44 83 44 56
p-value 0.151 0.971 0.852 0.409
AT, acute tonsillitis; PTA, peritonsillar abscess
https://doi.org/10.1371/journal.pone.0228122.t002
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symptoms (unilaterality, absence of common cold, fever) or presence of tonsillar erythema or
exudate in the AT or PTA group. Oral health had no impact on bacterial findings in either
group.
In patients treated with prior antibiotics, SAG was found more frequently than other bacte-
ria (p = 0.037). Patients with SAG were significantly older (median age 45 years, range 27–53
years) than patients with the following other bacteria: GAS (median age 30 years, range 20–58
years), non-SAG/beta-hemolytic streptococci/FN (median age 31.5 years, range 18–65 years),
or FN and FN+SAG (median age 25.5 years, range 16–37 years; p = 0.022). Seven out of nine
patients (77.8%) with SAG were male.
Discussion
Some of the PTA patients in this study had no tonsillar findings at clinical examination. In
contrast, all AT patients had tonsillar erythema, tonsillar exudate, or both. PTA patients pre-
senting without tonsillar erythema and tonsillar exudate had significantly lower S-CRP levels
than PTA patients with tonsillar findings. These eight patients without tonsillar findings were
also older than other PTA patients. Thus, patient characteristics, S-CRP, S-Amyl, and clinical
findings may be tools for differentiating PTA patient subgroups with different etiological fac-
tors [3, 5]. In addition, we found an inverse correlation between S-Amyl and S-CRP levels and
lower S-CRP and higher S-Amyl levels in afebrile AT patients compared to those with fever.
Fig 2. Distribution of serum proteins in PTA patients with different tonsillar findings. (A) C-reactive protein
(S-CRP) and (B) amylase (S-Amyl). 1, tonsillar erythema; 2, tonsillar exudate; 3, no findings; 4, tonsillar erythema and
exudate.
https://doi.org/10.1371/journal.pone.0228122.g002
Table 3. Bacterial findings in patients with AT or PTA.
Variable ATa PTA
Number of samples 54 56
Bacterial findings, n (%)
Aerobic bacteria
Beta-hemolytic streptococci 24 (44.4) 16 (22.2)
Group A streptococci 22 (40.7) 13 (18.1)
Group B, C, or G streptococci 2 (3.7) 3 (4.2)
Streptococcus anginosus group 0 (0) 11 (15.3)
Haemophilus influenzae 2 (3.7) 1 (1.4)
Neisseria meningitidis 0 (0) 1 (1.4)
Staphylococcus aureus 0 (0) 3 (4.2)
Other aerobic bacteria 0 (0) 0 (0)
Anaerobic bacteria
Fusobacterium necrophorum 5 (6.9)
Other anaerobic bacteriab 22 (30.6)
Mixed regional flora 28 (51.9) 13 (18.1)
AT, acute tonsillitis; PTA, peritonsillar abscess
a Only aerobic culture was performed for patients with acute tonsillitis (AT).
b Other anaerobic bacteria isolated: anaerobic Gram-negative rods (n = 14), Prevotella species (n = 2), Fusobacterium
species other than necrophorum (n = 4), anaerobic mixed flora (n = 2).
https://doi.org/10.1371/journal.pone.0228122.t003
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Strengths and limitations of the study
This prospective study is the first study to compare both S-CRP and S-Amyl between AT and
PTA patients, as well as between patients with different signs and symptoms of infection. One
limitation of this study is that only aerobic bacteria were analyzed in superficial throat bacterial
cultures. In addition, though both aerobes and anaerobes were tested in pus samples, some
bacterial findings were so few that it limited the statistical analysis. We did not exclude AT
patients with earlier PTA (n = 3) from the study, which could have affected the results, but our
cohort included very few of these patients. Patients with alcohol abuse and pancreatic disease
were excluded from the study, and none of the patients were pregnant, but patients with other
conditions causing elevated S-Amyl, such as gastrointestinal tract infections, eating disorders,
drug use, renal dysfunction, and macroamylasemia, were not excluded. Furthermore, the eval-
uation of tonsillar findings (erythema, exudate) was based on subjective observation by ear,
nose, and throat physicians. However, due to prospective nature of the study, as well physi-
cians’ substantial experience with tonsillar diseases, the evaluation can be considered reliable.
Oral health was also evaluated by an ear, nose, and throat physician, not a dentist, and classi-
fied only as good/poor. We used the standard reference values to analyze S-Amyl and did not
have the baseline S-Amyl value for the 112 patients. Therefore, it is impossible to determine
the actual change in S-Amyl values caused by the infection. Our material is consistent with
previous studies concerning patient age, gender, oral health, and smoking habits [2, 9, 19, 24].
Comparison with other studies
No earlier studies have compared S-CRP and S-Amyl levels between PTA patients with differ-
ent signs and symptoms. In our study, we observed a group of PTA patients without tonsillar
findings. Compared to patients with AT or PTA with tonsillar findings, these patients had
lower S-CRP levels and were older. In AT and PTA patients, an inverse correlation between
S-Amyl and S-CRP levels was evident. Similar findings have been reported in patients with
infection of major salivary glands. Saarinen et al. demonstrated that the majority of patients
suffering from parotitis had elevated S-Amyl levels (median 261 U/l, range 24–1220), but only
half of the patients had significantly elevated S-CRP levels >40 mg/l; 32% of the patients had
normal S-CRP < 5 mg/l (median 13.0 mg/l, range 5–170 mg/l) [25]. These similar findings
between our eight PTA patients and patients with confirmed infection of the major salivary
glands suggests that the PTA in these eight patients was due to infection of the minor salivary
glands [25–28]. One possible reason that S-Amyl levels in PTA patients remain below the ref-
erence values is the small size of the minor salivary glands relative to major salivary glands,
which prevents the elevation from becoming substantial. In addition, S-Amyl reference values
are validated for the diagnosis of pancreatic diseases and may not be directly adaptable to
reflect the activity of minor salivary glands. For a more reliable analysis of changes in S-Amyl
in PTA patients, we should define the baseline S-Amyl levels in these patients and prefer
S-Amyl measurements over salivary amylase.
We found no difference in S-Amyl levels between patients with and without a history of
recurrent AT or PTA. This observation differs from an earlier study demonstrating signifi-
cantly lower pus amylase levels in patients with a recurrent PTA [16]. Tachibana et al. previ-
ously showed no difference in S-CRP levels between AT and PTA patients. Our observations
were similar [14].
We also observed that afebrile AT patients have lower S-CRP and higher S-Amyl levels than
AT patients with fever. One could speculate that salivary gland activation sometimes occurs in
AT, though this hypothesis has not been presented previously [4, 29]. AT patients with unilat-
eral symptoms had lower S-CRP and higher S-Amyl levels than patients with bilateral throat
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pain, which could also indicate activity in the minor salivary glands. We compared S-Amyl lev-
els between PTA and AT patients and did not observe a difference between the groups. El
Saied et al. previously demonstrated a difference in both serum and pus amylase levels between
PTA patients and patients with deep neck abscesses and dental abscesses [16, 17].
In our study, GAS was the most prevalent bacterial finding in PTA patients, followed by
SAG and FN. In a recent Danish study of PTA, FN was the predominant pathogen, GAS was
the second most common, and group C Streptococcus was the third [22]. In this study, SAG
was found in older patients and predominately in males. Furthermore, SAG has been shown
to predict the rapid recurrence of PTA and to be found in older male patients [21, 30].
Clinical applicability of the study
Our results suggest that the pathogenesis of PTA may differ between patients; thus, patient
characteristics, S-CRP and amylase levels, and clinical findings may be useful tools for differ-
entiating these PTA subgroups. For example, when differentiating between subgroups of PTA
patients, we could identify patients who would benefit from TE after the first PTA episode.
Further studies are needed to clarify the usability of these variables and their significance in
helping choose the optimal treatment strategy for different PTA patients.
Conclusion
The etiology of PTA is not as unambiguous as previously thought. Bacteria may not be the
only factor determining the course of the disease. There seems to be a subgroup of PTA
patients without signs of tonsillar infection that share features with parotitis. Therefore, it may
be possible for PTA in these patients to not begin as a complication of AT, but as an infection
of the minor salivary glands. More research is needed to examine the different subgroups of
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